(Q64131862)

English

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

author name string

A Vernon

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

W Burman

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

D Benator

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Khan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L Bozeman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

353

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

9167

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1843-1847

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of patients with advanced cancer using the Karnofsky performance status

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The rpoB gene of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for rifampin mono-resistant tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifampin-monoresistant tuberculosis in New York City, 1993-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Low antituberculosis drug concentrations in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2911467-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)11467-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10359410%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64131862&oldid=1602968046"